Upon binding of its ligands: CSF-1 or IL-34, dimerization and activation of CSF1R consequently catalyzes the transfer of ATP phosphate to its tyrosine residue44,63, thus triggers breast cancer cell proliferation22,25, metastasis23,31, and angiogenesis19 pathways. The gene discussed is IL34; the disease is breast carcinoma.